European molecular diagnostics leader Qiagen (QGEN.US) receives a takeover offer from EQT: €46.50 per share, representing a 40.3% premium to the July share price

智通财经2026/10/22 13:21

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Smart Finance APP has learned that Qiagen (QGEN.US) announced on Thursday that it has agreed to accept an all-cash public acquisition offer from private equity firm EQT Group. The transaction values the European molecular diagnostics company at approximately 10.8 billion euros.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

European molecular diagnostics leader Qiagen (QGEN.US) receives a takeover offer from EQT: €46.50 per share, representing a 40.3% premium to the July share price

You may also like

Crypto prices